Home/Filings/4/0001213900-18-005279
4//SEC Filing

Keret Yosef 4

Accession 0001213900-18-005279

CIK 0001218683other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 12:04 PM ET

Size

5.5 KB

Accession

0001213900-18-005279

Insider Transaction Report

Form 4
Period: 2018-04-04
Keret Yosef
Director
Transactions
  • Award

    Stock Option (right to buy)

    2018-04-04+25,0000 total
    Exercise: $3.59Exp: 2025-04-04Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.
  • [F2]The Stock Option was granted as compensation for services as a director of the Issuer.

Issuer

Wize Pharma, Inc.

CIK 0001218683

Entity typeother

Related Parties

1
  • filerCIK 0001722972

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 12:04 PM ET
Size
5.5 KB